News summary

Multidimensional Regulation of Hepatic Macrophages in Chronic Liver Disease: From Metabolic Reprogramming to Intercellular and Interorgan Crosstalk

Source: Frontiers - Health • Published: 17 Sept 2026, 00:00

Summarized by Masters of Longevity from Frontiers - Health.

Review synthesizes recent advances in hepatic macrophage biology across chronic liver diseases, emphasizing metabolic rewiring, spatial heterogeneity, and intercellular and interorgan crosstalk.

Multidimensional Regulation of Hepatic Macrophages in Chronic Liver Disease: From Metabolic Reprogramming to Intercellular and Interorgan Crosstalk
Key Takeaways
  • You have multiple emails registered with Frontiers: You don't have a Frontiers account ?.
  • Beyond the outdated binary M1/M2 classification, tissue-resident macrophages (ResMø) and recruited monocyte-derived macrophages (MDMs) differentiate into disease-specific subsets (LAMs, SAMs, SenAMs) with spatially restricted, context-dependent functions.
  • Macrophage-derived autophagy, LC3-associated phagocytosis (LAP), and exosomal cargo transfer represent pivotal functional executors mediating intercellular signal transmission.
Read the full article at Frontiers - Health

Continue exploring

Recommended MoL Picks

MoL PickApoB: The cholesterol signal LDL can missIn longevity medicine, the useful biomarkers are not always the exotic ones. ApoB is a relatively simple blood test that can sharpen cardiovascular prevention when LDL-C looks reassuring but particle burden remains high.MoL PickThe Next Obesity-Drug Race Is About What Weight You LoseRegeneron’s myostatin and activin A antibodies point to a sharper question for the GLP-1 era: not whether people can lose more weight, but whether medicine can preserve the tissue that makes weight loss healthier.MoL PickSemaglutide Extended Lifespan in Mice. What Would Make It a Human Longevity Drug?A new animal study sharpens an important question: when do benefits in a particular disease become evidence for a longer, healthier life?